Zealand Pharma A/S (CPH:ZEAL)
Denmark flag Denmark · Delayed Price · Currency is DKK
536.60
+16.00 (3.07%)
At close: Nov 26, 2025

Zealand Pharma Revenue

Zealand Pharma had revenue of 49.57M DKK in the quarter ending September 30, 2025, with 1,022.74% growth. This brings the company's revenue in the last twelve months to 9.16B, up 11,809.72% year-over-year. In the year 2024, Zealand Pharma had annual revenue of 62.69M, down -81.71%.

Revenue (ttm)
9.16B
Revenue Growth
+11,809.72%
P/S Ratio
4.12
Revenue / Employee
20.81M
Employees
335
Market Cap
37.72B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202462.69M-280.10M-81.71%
Dec 31, 2023342.79M238.80M229.65%
Dec 31, 2022103.99M-4.56M-4.20%
Dec 31, 2021108.55M-83.46M-43.47%
Dec 31, 2020192.00M150.67M364.52%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Novo Nordisk315.60B
Coloplast27.87B
Genmab24.48B
H. Lundbeck24.08B
Demant22.59B
GN Store Nord17.12B
Bavarian Nordic6.89B
ALK-Abelló6.08B
Revenue Rankings